NCT01332565
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Cypress, California, United States
Clinical trial condition
Infection, Human Immunodeficiency Virus
Explore clinical trials studying Infection, Human Immunodeficiency Virus. Study availability and eligibility vary by location and protocol.
107 public trials
1 recruiting study
Infection, Human Immunodeficiency Virus trial results
Completed
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
NCT00085943
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Sacramento, California, United States
NCT01138072
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
Completed
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
NCT00363142
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Fountain Valley, California, United States
NCT00920088
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States
NCT00774735
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Completed
DDI Study of Etravirine and GSK1265744
NCT00920296
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site San Antonio, Texas, United States